药物开发和监管事务的演变:人工智能的证明力量
Linda Nene1, Brian Thabile Flepisi1, Sarel Jacobus Brand2
1Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Clinical therapeutics
|July 9, 2024
概括
人工智能 (AI) 应用通过加强信息管理来简化药物开发和监管过程. 需要进一步的监管指导来优化人工智能.
科学领域:
- 药物开发 药物开发
- 监管科学 监管科学
- 人工智能的人工智能
背景情况:
- 人工智能 (AI) 模仿人类认知功能,具有广泛的行业应用.
- 人工智能已经准备好改变药物开发和监管监督.
- 有限的公布证据存在于这个领域的真实世界AI应用.
研究的目的:
- 为了调查,整理和阐明AI在药物开发中的应用.
- 检查人工智能在简化药品监管过程中的作用.
主要方法:
- 进行了叙事审查.
- 审查的重点是确定和分析AI对药物开发和监管工作流程的影响.
主要成果:
- 机器学习,深度学习,自然语言处理和机器人过程自动化是人工智能的关键应用.
- 人工智能工具在药物开发过程中改善了信息获取和决策管理.
- 监管机构需要进一步指导AI实施的安全性,工作流程和成本影响.
结论:
- 人工智能在药物开发中具有显著的实用性,提高了效率和决策.
- 需要进行进一步的研究,以评估人工智能的转化价值,以节省必要药物输送的成本和时间.
更多相关视频
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
150
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
150
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Drug Administration and Therapy Phases: Overview
446
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


